+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Controlled-Release Drug Delivery Technology Market by Technology, Route Of Administration, Therapeutic Area, Drug Type, Formulation, End User - Global Forecast to 2030- Product Image
Controlled-Release Drug Delivery Technology Market by Technology, Route Of Administration, Therapeutic Area, Drug Type, Formulation, End User - Global Forecast to 2030- Product Image
Sale

Controlled-Release Drug Delivery Technology Market by Technology, Route Of Administration, Therapeutic Area, Drug Type, Formulation, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082145
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Controlled-release drug delivery is transforming the pharmaceutical landscape, enabling optimized patient care and more predictable therapeutic results. This market research report delivers a comprehensive analysis tailored for senior executives navigating investment, partnership, and operational decisions in this dynamic sector.

Market Snapshot: Controlled-Release Drug Delivery Market

The controlled-release drug delivery market has entered a growth phase, propelled by demand for patient-centric solutions, regulatory support for innovation, and an expanding array of advanced platform technologies. Market leaders benefit from established infrastructure, while emerging and mid-tier firms leverage agile development and specialized expertise. End-users span healthcare facilities, specialty clinics, and increasingly, home-care settings, highlighting broad adoption potential. The sector offers significant opportunities for differentiation through technology, route of administration, therapeutic application, and strategic alliances across value chains.

Scope & Segmentation

This report comprehensively segments the controlled-release drug delivery market by key criteria, providing granular coverage for strategic planning and investment.

  • Technology: Hydrogel (including pH-sensitive and temperature-sensitive types), Ion Exchange (anionic and cationic subtypes), Matrix (natural and synthetic polymers), Osmotic (elementary and push-pull pumps), Reservoir (encapsulated core and film coating designs).
  • Route of Administration: Implantable (contraceptive, intratumoral), Nasal (drops, sprays), Oral (capsules, tablets), Pulmonary (inhaler, nebulizer), Transdermal (patch-based).
  • Therapeutic Area: Cardiovascular (hyperlipidemia, hypertension), CNS (epilepsy, Parkinson’s disease), Metabolic (diabetes, obesity), Oncology (breast, lung cancer), Pain Management (chronic, postoperative).
  • Drug Type: Biologics (monoclonal antibodies, recombinant proteins), Peptides, Small Molecules, Vaccines (inactivated, live attenuated).
  • Formulation: Implantable (biodegradable, non-biodegradable), Microsphere (chitosan, PLGA-based), Patch (matrix and reservoir), Tablet (matrix and reservoir).
  • End User: Hospitals & Clinics (including ambulatory surgical centers), Specialty Clinics (oncology, pain management), Homecare (home infusion, self-administration).
  • Geographical Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (across 20+ countries), Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia, and others).
  • Key Companies Profiled: Johnson & Johnson, Novartis AG, Pfizer Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Abbott Laboratories, Takeda Pharmaceutical Company Limited, Baxter International Inc., AstraZeneca PLC.

Advanced segmentation supports targeted strategy formulation, with detailed analysis across technologies, regions, and application types that reveal actionable opportunities for diversification, investment, and partnership.

Key Takeaways for Senior Decision-Makers

  • Platform innovation is driving the migration from conventional drug delivery to programmable release, extending product lifecycles and improving therapeutic consistency.
  • Integration with diagnostic and digital health technologies enables precision dosing and situational monitoring, supporting the move toward personalized and adaptive therapies.
  • Legacy and emerging companies are increasingly collaborating to accelerate access to key technologies, with bolt-on acquisitions and licensing arrangements strengthening product portfolios.
  • Formulation advances—such as biodegradable implants and microspheres—address compliance and adherence challenges in chronic and complex conditions.
  • Regional policy shifts and reimbursement priorities shape adoption trends, with North America leading in innovation and approval, Asia-Pacific in expansion and domestic capability-building, and EMEA in regulatory harmonization.
  • Diversifying supply networks and investing in local production are crucial for minimizing exposure to supply chain volatility and shifting global trade policies.

Tariff Impact on the Controlled-Release Supply Chain

The 2025 US tariff regime has increased input and packaging costs, directly affecting manufacturers reliant on international suppliers for polymers, excipients, and advanced device components. In response, leading firms are adopting procurement diversification, backward integration, and local supply sourcing. These changes also encourage material innovation, with greater emphasis on recyclable and regionally available feedstocks. Regulatory oversight supports these adaptive efforts, acknowledging supply chain resilience as critical to sustained therapeutic delivery.

Methodology & Data Sources

This analysis employs a combined primary and secondary research approach. Qualitative interviews with industry stakeholders capture priorities and innovation drivers, while systematic reviews of regulatory filings and peer-reviewed literature ensure broad technology coverage. Quantitative analysis leverages clinical trial registries, patent trends, and manufacturing metrics, with data triangulated through expert validation for rigorous, actionable findings.

Why This Report Matters

  • Enables informed investment, M&A, and operational decisions by providing segment-level intelligence on technology, formulation, end-user, and regional dynamics.
  • Offers executive-ready guidance on risk mitigation in the face of tariff shifts, supply chain bottlenecks, and evolving regulatory standards.
  • Delivers competitive benchmarking for evaluating market positioning and partnership opportunities among both established and emerging players.

Conclusion

Controlled-release drug delivery markets are evolving, shaped by technology innovations, regulatory adaptation, and shifting global supply frameworks. Senior leadership will benefit from aligning investment with these themes to capture growth, manage risk, and deliver impactful therapeutic solutions.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Controlled-Release Drug Delivery Technology Market, by Technology
8.1. Introduction
8.2. Hydrogel
8.2.1. pH-Sensitive
8.2.2. Temperature-Sensitive
8.3. Ion Exchange
8.3.1. Anionic
8.3.2. Cationic
8.4. Matrix
8.4.1. Natural Polymer
8.4.2. Synthetic Polymer
8.5. Osmotic
8.5.1. Elementary Osmotic Pump
8.5.2. Push-Pull Osmotic Pump
8.6. Reservoir
8.6.1. Encapsulated Reservoir
8.6.2. Film Coating
9. Controlled-Release Drug Delivery Technology Market, by Route Of Administration
9.1. Introduction
9.2. Implantable
9.2.1. Contraceptive
9.2.2. Intratumoral
9.3. Nasal
9.3.1. Drops
9.3.2. Spray
9.4. Oral
9.4.1. Capsule
9.4.2. Tablet
9.5. Pulmonary
9.5.1. Inhaler
9.5.2. Nebulizer
9.6. Transdermal
9.6.1. Patch
10. Controlled-Release Drug Delivery Technology Market, by Therapeutic Area
10.1. Introduction
10.2. Cardiovascular
10.2.1. Hyperlipidemia
10.2.2. Hypertension
10.3. CNS
10.3.1. Epilepsy
10.3.2. Parkinsons
10.4. Metabolic
10.4.1. Diabetes
10.4.2. Obesity
10.5. Oncology
10.5.1. Breast Cancer
10.5.2. Lung Cancer
10.6. Pain Management
10.6.1. Chronic Pain
10.6.2. Postoperative Pain
11. Controlled-Release Drug Delivery Technology Market, by Drug Type
11.1. Introduction
11.2. Biologic
11.2.1. Monoclonal Antibody
11.2.2. Recombinant Protein
11.3. Peptide
11.4. Small Molecule
11.5. Vaccine
11.5.1. Inactivated
11.5.2. Live Attenuated
12. Controlled-Release Drug Delivery Technology Market, by Formulation
12.1. Introduction
12.2. Implant
12.2.1. Biodegradable
12.2.2. Non-Biodegradable
12.3. Microsphere
12.3.1. Chitosan
12.3.2. PLGA
12.4. Patch
12.4.1. Matrix Patch
12.4.2. Reservoir Patch
12.5. Tablet
12.5.1. Matrix Tablet
12.5.2. Reservoir Tablet
13. Controlled-Release Drug Delivery Technology Market, by End User
13.1. Introduction
13.2. Homecare
13.2.1. Home Infusion
13.2.2. Self-Administration
13.3. Hospitals & Clinics
13.3.1. Ambulatory Surgical Centres
13.3.2. Hospitals
13.4. Specialty Clinics
13.4.1. Oncology Clinics
13.4.2. Pain Clinics
14. Americas Controlled-Release Drug Delivery Technology Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Controlled-Release Drug Delivery Technology Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Controlled-Release Drug Delivery Technology Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Johnson & Johnson
17.3.2. Novartis AG
17.3.3. Pfizer Inc.
17.3.4. Sanofi S.A.
17.3.5. Teva Pharmaceutical Industries Ltd.
17.3.6. Merck & Co., Inc.
17.3.7. Abbott Laboratories
17.3.8. Takeda Pharmaceutical Company Limited
17.3.9. Baxter International Inc.
17.3.10. AstraZeneca PLC
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET MULTI-CURRENCY
FIGURE 2. CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET MULTI-LANGUAGE
FIGURE 3. CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HYDROGEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PH-SENSITIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TEMPERATURE-SENSITIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HYDROGEL, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ION EXCHANGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ANIONIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CATIONIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ION EXCHANGE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MATRIX, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NATURAL POLYMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYNTHETIC POLYMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MATRIX, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY OSMOTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ELEMENTARY OSMOTIC PUMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PUSH-PULL OSMOTIC PUMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY OSMOTIC, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RESERVOIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ENCAPSULATED RESERVOIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FILM COATING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RESERVOIR, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTRACEPTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY INTRATUMORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NASAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DROPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PULMONARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PULMONARY, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HYPERLIPIDEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CNS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PARKINSONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CNS, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY METABOLIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY OBESITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY METABOLIC, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY POSTOPERATIVE PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY BIOLOGIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY BIOLOGIC, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PEPTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NON-BIODEGRADABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANT, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MICROSPHERE, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CHITOSAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PLGA, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MICROSPHERE, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MATRIX PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RESERVOIR PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PATCH, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MATRIX TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RESERVOIR TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 98. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOME INFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 99. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SELF-ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 100. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 101. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 102. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 103. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 104. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 105. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 106. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 107. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PAIN CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 108. GLOBAL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HYDROGEL, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ION EXCHANGE, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MATRIX, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY OSMOTIC, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RESERVOIR, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PULMONARY, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 123. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CNS, 2018-2030 (USD MILLION)
TABLE 124. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY METABOLIC, 2018-2030 (USD MILLION)
TABLE 125. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 126. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 127. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 128. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY BIOLOGIC, 2018-2030 (USD MILLION)
TABLE 129. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 130. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 131. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANT, 2018-2030 (USD MILLION)
TABLE 132. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MICROSPHERE, 2018-2030 (USD MILLION)
TABLE 133. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PATCH, 2018-2030 (USD MILLION)
TABLE 134. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 135. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 137. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 138. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 139. AMERICAS CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HYDROGEL, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ION EXCHANGE, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MATRIX, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY OSMOTIC, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RESERVOIR, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PULMONARY, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CNS, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY METABOLIC, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY BIOLOGIC, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 162. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANT, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MICROSPHERE, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PATCH, 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 166. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 168. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 169. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 170. UNITED STATES CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 171. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 172. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HYDROGEL, 2018-2030 (USD MILLION)
TABLE 173. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ION EXCHANGE, 2018-2030 (USD MILLION)
TABLE 174. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MATRIX, 2018-2030 (USD MILLION)
TABLE 175. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY OSMOTIC, 2018-2030 (USD MILLION)
TABLE 176. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RESERVOIR, 2018-2030 (USD MILLION)
TABLE 177. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 178. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
TABLE 179. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 180. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 181. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PULMONARY, 2018-2030 (USD MILLION)
TABLE 182. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 183. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 184. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 185. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CNS, 2018-2030 (USD MILLION)
TABLE 186. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY METABOLIC, 2018-2030 (USD MILLION)
TABLE 187. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 188. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 189. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 190. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY BIOLOGIC, 2018-2030 (USD MILLION)
TABLE 191. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 192. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 193. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANT, 2018-2030 (USD MILLION)
TABLE 194. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MICROSPHERE, 2018-2030 (USD MILLION)
TABLE 195. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PATCH, 2018-2030 (USD MILLION)
TABLE 196. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 197. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 199. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 200. CANADA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 201. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HYDROGEL, 2018-2030 (USD MILLION)
TABLE 203. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ION EXCHANGE, 2018-2030 (USD MILLION)
TABLE 204. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MATRIX, 2018-2030 (USD MILLION)
TABLE 205. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY OSMOTIC, 2018-2030 (USD MILLION)
TABLE 206. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RESERVOIR, 2018-2030 (USD MILLION)
TABLE 207. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 208. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
TABLE 209. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 210. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 211. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PULMONARY, 2018-2030 (USD MILLION)
TABLE 212. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 213. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 214. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 215. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CNS, 2018-2030 (USD MILLION)
TABLE 216. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY METABOLIC, 2018-2030 (USD MILLION)
TABLE 217. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 218. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 219. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 220. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY BIOLOGIC, 2018-2030 (USD MILLION)
TABLE 221. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 222. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 223. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANT, 2018-2030 (USD MILLION)
TABLE 224. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MICROSPHERE, 2018-2030 (USD MILLION)
TABLE 225. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PATCH, 2018-2030 (USD MILLION)
TABLE 226. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 227. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 229. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 230. MEXICO CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 231. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HYDROGEL, 2018-2030 (USD MILLION)
TABLE 233. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ION EXCHANGE, 2018-2030 (USD MILLION)
TABLE 234. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MATRIX, 2018-2030 (USD MILLION)
TABLE 235. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY OSMOTIC, 2018-2030 (USD MILLION)
TABLE 236. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RESERVOIR, 2018-2030 (USD MILLION)
TABLE 237. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 238. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
TABLE 239. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 240. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 241. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PULMONARY, 2018-2030 (USD MILLION)
TABLE 242. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 243. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 244. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 245. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CNS, 2018-2030 (USD MILLION)
TABLE 246. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY METABOLIC, 2018-2030 (USD MILLION)
TABLE 247. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 248. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 249. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 250. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY BIOLOGIC, 2018-2030 (USD MILLION)
TABLE 251. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 252. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 253. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANT, 2018-2030 (USD MILLION)
TABLE 254. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MICROSPHERE, 2018-2030 (USD MILLION)
TABLE 255. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PATCH, 2018-2030 (USD MILLION)
TABLE 256. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 257. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 259. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 260. BRAZIL CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 261. ARGENTINA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 262. ARGENTINA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY HYDROGEL, 2018-2030 (USD MILLION)
TABLE 263. ARGENTINA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ION EXCHANGE, 2018-2030 (USD MILLION)
TABLE 264. ARGENTINA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY MATRIX, 2018-2030 (USD MILLION)
TABLE 265. ARGENTINA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY OSMOTIC, 2018-2030 (USD MILLION)
TABLE 266. ARGENTINA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY RESERVOIR, 2018-2030 (USD MILLION)
TABLE 267. ARGENTINA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 268. ARGENTINA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
TABLE 269. ARGENTINA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY NASAL, 2018-2030 (USD MILLION)
TABLE 270. ARGENTINA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 271. ARGENTINA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PULMONARY, 2018-2030 (USD MILLION)
TABLE 272. ARGENTINA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 273. ARGENTINA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 274. ARGENTINA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 275. ARGENTINA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CNS, 2018-2030 (USD MILLION)
TABLE 276. ARGENTINA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY METABOLIC, 2018-2030 (USD MILLION)
TABLE 277. ARGENTINA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 278. ARGENTINA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 279. ARGENTINA CONTROLLED-RELEASE DRUG DELIVERY TECHNOLOGY MARKET SIZ

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Controlled-Release Drug Delivery Technology market report include:
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • Abbott Laboratories
  • Takeda Pharmaceutical Company Limited
  • Baxter International Inc.
  • AstraZeneca PLC

Related Topics

Related Reports

Controlled Release Drug Delivery Market by Route, Polymer, Type, Application, Technology, Drug Type, End User - Global Forecast to 2030 - Product Image

Controlled Release Drug Delivery Market by Route, Polymer, Type, Application, Technology, Drug Type, End User - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
Controlled Release Drug Delivery - Global Strategic Business Report - Product Image

Controlled Release Drug Delivery - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Controlled Release Drug Delivery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Controlled Release Drug Delivery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 186 Pages
  • Global
From
Controlled Release Drug Delivery Market Report 2025 - Product Image

Controlled Release Drug Delivery Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Oral Controlled Release Drug Delivery Technology Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Oral Controlled Release Drug Delivery Technology Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 86 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.